Financial Health Assessment: A.C. PUDDLE & CO. LIMITED

Patient: A.C. Puddle & Co. Limited (01168355) — plumbing, heat and air-conditioning installation, Pontypool, Gwent Age: Incorporated 29 April 1974 (51 years trading) Constitution: Private limited company, micro-entity, FRS 105 filleted accounts, unaudited Last examination: Balance sheet to 30 April 2025 (detailed figures); filings current, nothing overdue

Note: this is an analytical review of publicly filed accounts. I'm not a qualified accountant, and the abridged micro-entity accounts omit the profit and loss account, so several important readings simply aren't available from the public record.

1. Financial Health Score: C+

"Satisfactory but deteriorating — stable at rest, trending wrong under load."

The company is not in distress — it is solvent, debt-free on a long-term basis, and has survived five decades of trading cycles. But three consecutive years of eroding reserves and a working capital cushion of just £4,065 on a £157,174 balance sheet are genuine symptoms, not noise. A C+ that drifts to a C if the current trajectory holds for one more year.

2. Key Vital Signs

Reading each one:

• Working capital of £4,065 (2.6% of total assets). This is the pulse. It's positive, but it's a rounding error against the size of the balance sheet. A current ratio of 1.07 means roughly a 6% adverse move in current assets or current liabilities would tip the company into negative working capital — the point where it starts relying on timing luck to pay wages and suppliers.
• Creditors up 19%, faster than current assets (+16.4%). Suppliers and short-term lenders are financing a larger share of the business than a year ago.
• Fixed assets flat at £91,345. Additions are running at roughly the level of depreciation. In a trade business, that means vans, tools and equipment are being replaced but not renewed or expanded. Not an emergency — but a slow ageing of the asset base.
• Accruals and deferred income up 77%. Could be customer deposits for work not yet completed (benign, even healthy for cash), or mounting accrued costs (less benign). Worth confirming which.
• Equity ratio 57.9%, down from 63.2%. Still respectable. The company's own money funds more than half of everything it owns.
• No long-term liabilities at all. Every liability on the balance sheet falls due within a year. That's low financial risk — no lender covenants, no refinancing cliff — but it also means there is no long-term capital structure supporting investment.
• Net assets (£91,025) vs fixed assets (£91,345). Long-term assets are 99.6% covered by shareholders' funds — just below the 100% line. A sliver of the company's long-term assets is effectively funded by short-term credit.

3. Symptoms Analysis

Symptom 1 — Growth without profit. Total assets rose £9,278 while total liabilities rose £11,766. Net assets fell £2,488. In plain terms: the business expanded its balance sheet this year, but the expansion was paid for by creditors, not by earnings. That is the single most important finding in these accounts.

Symptom 2 — A three-year decline in reserves. Net assets peaked at £131,651 in 2022 and have fallen every year since: −£10,591 (−8.0%), then −£27,547 (−22.8%), then −£2,488 (−2.7%). Cumulative erosion of £40,626, or 30.9%. The rate of decline is decelerating sharply, which is encouraging — but the direction has not yet reversed.

Symptom 3 — The 2024 step-down needs explaining. A £27,547 fall in one year is far larger than the other two. Because micro-entity accounts don't include a profit and loss account, this could be (a) a loss-making year, (b) dividends or director drawings, or (c) an asset write-down. These have completely different prognoses. If it's dividends, it was a choice — possibly an unwise one against the reserve trend. If it's a loss, it's a symptom requiring treatment.

Symptom 4 — A balance sheet that has shrunk by a third. Total assets peaked at £236,308 in 2021 and now stand at £157,174 — down 33.5%, roughly 9.7% a year. Some of that is likely deliberate (asset disposals in 2023, when both assets and liabilities fell together). But the direction over four years is contraction, not consolidation.

Symptom 5 — Governance concentration. Five directors and five employees, with two individuals (Xxxxxx Xxxxxxxxname shown to subscribers and Xxxxxx Xxxxxxxxname shown to subscribers) each holding 25–50% of shares and voting rights. This is a classic multi-generational family firm. It carries real strengths — commitment, continuity, low staff turnover — and real risks: key-person dependency, no obvious independent oversight, and director remuneration competing directly with reserve rebuilding.

Symptom 6 — No visible profit data. The accounts are filleted, audit-exempt and micro-entity. Turnover, gross margin, net profit and debtor days are all invisible from the outside. This is like having an X-ray but no blood test: you can see the structure, not the chemistry.

What is not wrong — and matters. No overdue filings. No liquidation, administration or receivership. No director disqualification records. Positive net assets. Zero long-term debt. Fifty-one years of continuous trading. These are strong baseline vitals, and they should not be lost in the diagnosis.

4. Diagnosis

Chronic, slow-onset reserve erosion with early-stage liquidity strain — not acute distress.

The company presents as a mature, solvent, family-run contractor whose balance sheet has been quietly shrinking for three years while its short-term funding dependence has quietly grown. There is no insolvency event on the horizon based on these figures, and no evidence of creditor pressure. But the pattern is recognisable: a business that has stopped generating enough surplus to fund its own growth, and has begun bridging the gap with supplier credit and accruals.

The most likely underlying causes, in order of probability:

1. Margin compression — flat headcount, flat fixed assets, rising current assets and rising creditors is a classic signature of rising costs and/or slower debtor collection squeezing the middle.
2. Distributions exceeding profit — the 2024 step-down is large enough to suggest dividends or drawings taken against a business that couldn't comfortably afford them.
3. Working capital indiscipline — debtors and creditors both growing, with the creditor side growing faster.

The prognosis is genuinely good if the cause is identified. The 2025 decline of only £2,488 — the smallest of the three years — suggests the deterioration may already be flattening out.

5. Prognosis

The decelerating rate of decline is the strongest positive signal in the data. The single biggest risk is not the numbers themselves — it's that nobody is currently measuring them monthly, so a turn for the worse would only become visible at the next annual filing.

6. Recommendations

Immediate (next 30 days)

1. Get the blood test done. Produce monthly management accounts with turnover, gross margin, net profit, debtor days and creditor days. The public accounts cannot tell you whether this business is profitable; internal figures can. This is the highest-value action on the list.
2. Explain the 2024 step-down. Establish definitively whether the £27,547 fall was a loss, a dividend, or a write-down. The treatment plan differs completely depending on the answer.
3. Review the accruals jump. Confirm whether the £1,904 increase is customer deposits (good — cash in hand) or accrued costs (watch).

Short term (this financial year)

4. Set a working capital target. Aim for net current assets of £15,000–£25,000 (current ratio 1.25–1.5) rather than £4,065. Treat the shortfall as a funding goal, not an abstraction.
5. Tighten the debtor cycle. In a trade where materials are paid for upfront and labour is paid for later, every extra day of debtor days is borrowed money. Invoice promptly, chase systematically, consider a modest deposit policy on larger jobs.
6. Don't let supplier credit become the business's bank. Negotiate payment terms explicitly rather than drifting into them. Creditors at 93.8% of current assets is a warning light, not a facility.
7. Align dividends with retained profit. If distributions resume, they should come out of genuine post-tax surplus, with a reserve floor agreed by the board first.

Medium term (12–24 months)

8. Plan capital replacement. Fixed assets have been flat for years. Map the age and condition of vans, tools and equipment, and decide whether renewal should be funded from cash or from asset finance — the latter spreads the cost and protects working capital.
9. Address succession and key-person risk. With five directors and two controlling shareholders, document what happens on retirement, illness or death of a principal. Review shareholder agreements and consider key-person protection.
10. Check the compliance and tax housekeeping. Confirm CIS treatment if the company subcontracts into construction-related work, verify the director remuneration/pension mix is tax-efficient, and correct the minor iXBRL tagging gap where the accounts carry no description of principal activity.

Ongoing

11. Run a quarterly five-metric dashboard: net current assets, current ratio, debtor days, creditor days, and reserves. Five numbers, reviewed four times a year, would have flagged this three-year drift in year one.

Names of the people mentioned are shown to subscribers. See subscription